Abstract Background Indication for surgery in Crohn’s disease patients is a matter of ongoing debate. Increasing number of available medical treatments can lead to significant postponement of surgery in many patients. Later first abdominal surgery for Crohn’s disease is commonly seen as significant achievement of modern biological treatment. However, later surgery is not necessarily a success since it might only prolong unnecessary suffering. Thus, it is of a paramount importance to understand whether patients are “losing” or “winning” time by avoiding abdominal surgery. Patient reported outcome measurement – various indices, scores and Quality-of-Life measurement tools – are used to assess the degree of suffering and to calculate the treatment success. In present prospective study, we assessed the value of commonly used PROM tools to characterize disease severity in patients scheduled for bowel resection for Crohn’s disease. Methods Consecutive patients scheduled for bowel resection were assessed preoperatively using CDAI (Crohn’s disease activity index), IBD-DI (IBD Disability index) and the IBDQ (IBD questionnaire to assess quality of life). Also, patients were asked to rate their global health (GH) from 1 (unbearable) to 10 (perfectly good). Worse scoring was expected to be found in patients with disease complications which are frequent in surgical population: severe anemia (HB <10g/dl) weight loss of >10%, penetrating disease, intraabdominal abscess and emergency hospitalization before surgery. Results 109 patients were assessed. Conclusion PROM’s alone are not sufficient to guide the decision toward or against the potential surgery since “good” scores still miss some significant disease complications. Also, PROM’s are dynamic tools with scores differing significantly over time. Indication for surgery should be rather guided by expected risks and prognosis than by mere “disease activity”. Table 1 illustrates preoperative results of PROM’s assessment. An incongruence of all scores can be observed. While 34% of patients have a quiescent disease according to the CDAI, only 13.5 % according to IBD-Q. Table 2 demonstrates great inconsistency between the tools regarding their ability to predict severe disease (as illustrated by emergency hospitalization, significant weight loss, presence of intraabdominal abscess and penetrating disease). Only severe anemia led to significant worsening in all calculated tools.
Read full abstract